Selected-GenAtlas references SOURCE GeneCards NCBI Gene Swiss-Prot Ensembl
HGNC UniGene Nucleotide OMIM UCSC
Home Page
FLASH GENE
Symbol EPC1 contributors: mct/npt - updated : 16-12-2009
HGNC name enhancer of polycomb homolog 1, (Drosophila)
HGNC id 19876
EXPRESSION
Type widely
   expressed in (based on citations)
organ(s)
tissue
SystemTissueTissue level 1Tissue level 2LevelPubmedSpeciesStageRna symbol
Muscularstriatumskeletal highly
cell lineage
cell lines
fluid/secretion
at STAGE
physiological period embryo
Text highly expressed in the embryonic heart (Kee 2007)
PROTEIN
PHYSICAL PROPERTIES
STRUCTURE
motifs/domains
  • an activating EPcA domain
  • a repressive C terminal region
  • HOMOLOGY
    interspecies homolog to Drosophila enhancer of polycomb
    Homologene
    FAMILY
  • enhancer of polycomb family
  • CATEGORY regulatory , transcription factor
    SUBCELLULAR LOCALIZATION     intracellular
    intracellular,cytoplasm,organelle,mitochondria,matrix
    intracellular,nucleus,nucleoplasm
    text colocolizing with RFP
    basic FUNCTION
  • both repressive and transactivating transcriptional activities
  • plays a role in the initiation of skeletal muscle differentiation, and its interaction with HOPX is required for the full activity (Kee 2007)
  • recruits both serum response factor (SRF) and EP300 to induce skeletal muscle differentiation (Kim 2009)
  • required for skeletal muscle differentiation by recruiting both SRF and EP300 to the serum response element of muscle-specific gene promoters (Kim 2009)
  • CELLULAR PROCESS nucleotide, transcription, regulation
    PHYSIOLOGICAL PROCESS
    PATHWAY
    metabolism
    signaling
    a component
  • complexing with E2F6 (E2F6-EPC1 complex) (E2F6-EPC1 interacts with EZH2 and may regulate genes required for cell cycle progression) (Attwooll 2005)
  • INTERACTION
    DNA
    RNA
    small molecule
    protein
  • coiled-coil domain of RFP
  • complex (E2F6-EPC1) interacts with EZH2 and may regulate genes required for cell cycle progression
  • interacted physically with SRF
  • directly bound to EP300 in myoblast cells (Kim 2009)
  • cell & other
    REGULATION
    ASSOCIATED DISORDERS
    corresponding disease(s)
    Other morbid association(s)
    TypeGene ModificationChromosome rearrangementProtein expressionProtein Function
    tumoral fusion      
    fusion with ASXL2 (EPC1/ASXL2 enhanced cell growth in T-leukemia cells) (Nakahata 2009)
    Susceptibility
    Variant & Polymorphism
    Candidate gene
    Marker
    Therapy target
    ANIMAL & CELL MODELS